Trump taps Dr. Heidi Overton, top White House aide, to lead FDA

What This is

• President Donald Trump nominated Dr. Heidi Overton, a White House domestic policy aide and physician, to lead the Food and Drug Administration (FDA).
• The FDA commissioner job requires Senate confirmation before Overton could take office.
• The nomination follows the May resignation of FDA commissioner Marty Makary.
• Overton serves as deputy director of the White House Domestic Policy Council and previously worked at the America First Policy Institute.
• If confirmed, Overton would oversee areas including drug safety and tobacco regulation.
• Overton has supported proposals to reduce childhood vaccine requirements and has been involved in discussions about changing the childhood vaccine schedule.
• Reporting highlights her views on abortion, including calls for stricter controls on medication abortion.
• Sen. Bill Cassidy, who leads the Senate health committee, said he has strong concerns about Overton’s vaccine role and questioned her management experience at a time the FDA is facing staffing and morale problems.
• Some drug-industry leaders and investors said they are cautiously hopeful Overton could bring stability, but they also worry about politics shaping FDA decisions.

Why This Matters

• The FDA commissioner can shift how strictly the agency checks drug and food safety before products reach the public.
• A nominee linked to vaccine policy and abortion-pill limits can deepen distrust in FDA guidance among both supporters and critics.
• Senate confirmation is one of the few checks that can test a nominee’s experience and independence from White House politics.
• If the agency is losing staff and morale, leadership choices can affect how quickly it responds to safety issues and reviews new products.